Lusso P, Lori F, Gallo R C
Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20892.
J Virol. 1990 Dec;64(12):6341-4. doi: 10.1128/JVI.64.12.6341-6344.1990.
Although human immunodeficiency virus (HIV) is the causative agent of the acquired immunodeficiency syndrome and related disorders, it has been suggested that viral cofactors may accelerate the progression of the disease. We present evidence that human T lymphoid cells productively coinfected by HIV type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) or HTLV-II generate a progeny of phenotypically mixed viral particles that allow the penetration of HIV-1 into previously nonsusceptible CD4- human cells, including mature CD8+ T lymphocytes, B lymphoid cells, epithelial cells, and skeletal muscle cells. The infection is independent of the major HIV-1 receptor, (i.e., the CD4 glycoprotein) since OKT4a, a neutralizing anti-CD4 monoclonal antibody, fails to block the penetration of HIV-1. Similarly, infection is not inhibited by monoclonal antibody M77, directed toward the neutralizing loop of the gp120 envelope glycoprotein of HIV-1. In contrast, pretreatment of the virus stock with HTLV-I-neutralizing human serum completely abolishes the penetration of phenotypically mixed HIV-1 into CD4- cells. These results suggest that HTLV-I or HTLV-II may increase the pathogenicity of HIV-1 by broadening the spectrum of its cellular tropism and, thus, favoring its spread within the organism of coinfected hosts.
尽管人类免疫缺陷病毒(HIV)是获得性免疫缺陷综合征及相关疾病的病原体,但有研究表明病毒辅助因子可能会加速疾病的进展。我们提供的证据表明,被1型人类免疫缺陷病毒(HIV-1)与I型或II型人类T细胞白血病病毒(HTLV-I或HTLV-II)共同有效感染的人类T淋巴细胞会产生表型混合的病毒粒子后代,这些粒子能使HIV-1进入先前不易感染的CD4-人类细胞,包括成熟的CD8+ T淋巴细胞、B淋巴细胞、上皮细胞和骨骼肌细胞。这种感染不依赖于主要的HIV-1受体(即CD4糖蛋白),因为中和性抗CD4单克隆抗体OKT4a无法阻断HIV-1的侵入。同样,针对HIV-1 gp120包膜糖蛋白中和环的单克隆抗体M77也不能抑制感染。相反,用HTLV-I中和人血清预处理病毒储备液可完全消除表型混合的HIV-1对CD4-细胞的侵入。这些结果表明,HTLV-I或HTLV-II可能通过拓宽其细胞嗜性谱来增加HIV-1的致病性,从而有利于其在共感染宿主体内传播。